The Ipsos opinion poll commissioned by We Are Innovation has provided valuable insights into Swedes’ usage of Alternative Nicotine Products (ANPs). The survey revealed that health concerns were the primary motivator for ex-smokers to switch to ANPs. In addition, the survey found that nicotine levels were crucial in facilitating the switch from combustible cigarettes to safer nicotine alternatives. ANP users prefer products with different nicotine levels that match their smoking habits, making it easier for them to transition. The availability of different flavors in ANPs also makes them an attractive option for those looking for a taste alternative to traditional cigarettes. The findings emphasize the importance of providing a diverse range of ANPs with varying nicotine levels and flavors to help more people quit smoking and switch to a safer and healthier alternative. Affordable pricing and government support are also important factors.
The availability of a diverse range of ANPs was found to be crucial for quitting smoking, with more people turning to innovative alternatives such as nicotine pouches and vaping. Consumers also prioritized flavor and nicotine levels when choosing ANPs, with women emphasizing these factors more than men.
Affordability was found to be an important factor in driving smokers to switch to ANPs, with 61 percent of users believing that affordable or cheaper options than cigarettes were key to getting smokers to quit. Despite perceiving current attitudes from the government and public health as either hostile or neutral toward ANPs, over half of the consumers believed that the government should support the switch from traditional cigarettes.
The results of the Ipsos opinion poll commissioned by We Are Innovation are even more significant when considering Sweden’s smoke-free achievements. These findings highlight the remarkable impact that ANPs have had on public health and people’s quality of life in Sweden, contributing to the country’s progress toward becoming smoke-free by 2023. Sweden’s success is evident, with the lowest incidence of smoking-related diseases in Europe and the lowest rate of premature deaths from tobacco-related causes. Additionally, lung cancer deaths in Sweden are less than half the EU average, while total cancer deaths are 38 percent lower than the EU average, and cancer rates in Sweden are 41 percent lower than in the rest of the EU. The poll results underscore the importance of promoting and supporting the use of ANPs in the country to ensure that Sweden maintains its impressive progress toward a smoke-free future.
In conclusion, the Ipsos opinion poll commissioned by We Are Innovation provides valuable insights into Swedes’ views on alternatives to cigarettes and their usage of ANPs. The results highlight the need for a diverse range of affordable ANPs to be made available and for the government to be more supportive of the switch from traditional cigarettes to ANPs to improve public health outcomes.
